Vaccines
News from the FDA/CDC
CDC signs off on RSV vaccine for older adults
The vote recommending shared decision making about the vaccine, instead of a routine vaccination recommended for all, “is a weaker recommendation...
News from the FDA/CDC
FDA panel backs new COVID booster focusing only on variants
Panelists also raised other questions during the meeting, including concerns about moves toward tying COVID vaccinations into the model of annual...
Conference Coverage
Latest data: COVID vaccine safety, protection, and breakthrough infections in inflammatory, autoimmune diseases
EULAR 2023 served up a bevy of studies on the protection and safety of COVID vaccines for patients and pregnant and breastfeeding women, as well...
Latest News
The new vaccine your patients may not want
How can we incorporate the new RSV vaccine for older adults into our practices and overcome patient hesitancy to receive yet another vaccine?
Article
Severe rash after COVID-19 vaccination
The patient’s recent vaccine was the most remarkable thing about his medical history.
Latest News
Study of hospitalizations in Canada quantifies benefit of COVID-19 vaccine to reduce death, ICU admissions
Unvaccinated patients were found to be up to 15 times more likely to die from COVID-19 than fully vaccinated patients.
Conference Coverage
New drugs in primary care: Lessons learned from COVID-19
Nirmatrelvir-ritonavir has helped keep many patients out of the hospital, says internist.
News from the FDA/CDC
FDA approves first RSV vaccine for older adults
Older adults with underlying health conditions, such as lung or heart disease, are at high risk for severe disease.
Conference Coverage
‘Exciting’ results for cancer vaccine plus pembro in melanoma
A new randomized study is the first to demonstrate improvement in recurrence-free survival in melanoma with an individualized neoantigen vaccine...
News from the FDA/CDC
CDC backs FDA’s call for second COVID booster for those at high risk
The agency is following the recommendations made by its Advisory Committee on Immunization Practices (ACIP).
Latest News
Cancer, heart disease vaccines may be ready by 2030, Moderna says
The announcement is yet another sign of what many are calling “the golden age” of vaccine development.